Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – Discussed by Mark Brewer – Hardman & Co Analyst

Advanced Oncotherapy (AVO) – Discussed by Mark Brewer – Hardman & Co Analyst

By in Advanced Oncotherapy (AVO) on .

 

AVO1Mark Brewer – Hardman & Co Life Sciences Analyst discusses with DirectorsTalk Advanced Oncotherapy Plc, it’s unique technology, the market size, growth drivers, key risks and an outlook for the company.

Tags: , , , ,

Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.